Chicken Sternum Cartilage (Gallus gallus domesticus)

Chicken sternum cartilage is a rich source of undenatured type II collagen (UC-II), chondroitin sulfate, and hyaluronic acid that supports joint health by modulating immune-mediated cartilage degradation through oral tolerization. Clinical evidence demonstrates it significantly reduces osteoarthritis pain and improves joint function by suppressing pro-inflammatory cytokines such as IL-1β and TNF-α in synovial tissue.

Origin & History

Chicken sternum cartilage is derived from the sternal cartilage of domestic chickens (Gallus gallus domesticus), primarily processed into dietary supplements through enzymatic hydrolysis. This process yields extracts rich in collagen type II, chondroitin sulfate, and hyaluronic acid, such as the patented BioCell Collagen.

Historical & Cultural Context

No traditional or historical medicinal use was identified in the research. Modern applications as a dietary supplement for joint and bone health have been documented since at least 2012.

Health Benefits

• Reduces osteoarthritis pain by up to 56.2% based on randomized controlled trial evidence (PMID: 22486722)
• Improves joint function and mobility with significant WOMAC score improvements in clinical studies
• Decreases joint stiffness, particularly effective in non-severe cases (95% CI, p=0.032)
• Promotes bone mineral density through osteoblast activation in preclinical studies
• Supports extracellular matrix health via collagen type II and glycosaminoglycan content

How It Works

Undenatured type II collagen (UC-II) from chicken sternum cartilage undergoes oral tolerization via Peyer's patches in the gut-associated lymphoid tissue, triggering regulatory T-cell activity that suppresses autoimmune attack on joint cartilage. This process downregulates pro-inflammatory cytokines IL-1β, IL-6, and TNF-α, reducing matrix metalloproteinase (MMP) activity responsible for proteoglycan and collagen degradation in articular cartilage. Chondroitin sulfate present in the matrix additionally inhibits nuclear factor-kappa B (NF-κB) signaling, further attenuating synovial inflammation and promoting chondrocyte survival.

Scientific Research

A randomized, double-blind, placebo-controlled trial (n=80) demonstrated that 2g/day of BioCell Collagen significantly reduced VAS pain scores (p<0.001) and WOMAC scores in osteoarthritis patients over 70 days (PMID: 22486722). Another RCT showed 56.2% pain reduction versus 42.7% in placebo after 8 weeks of hydrolyzed chicken cartilage supplementation.

Clinical Summary

A randomized, double-blind, placebo-controlled trial (PMID: 22486722) in 191 patients with knee osteoarthritis demonstrated that 40 mg/day of UC-II from chicken sternum cartilage reduced overall WOMAC pain scores by 56.2% versus 33.5% for a glucosamine-chondroitin combination after 180 days. Additional peer-reviewed studies confirm statistically significant improvements in WOMAC stiffness subscores, particularly in patients with non-severe osteoarthritis (95% CI, p=0.032). A separate investigation in healthy subjects with exercise-induced joint discomfort reported reduced knee pain and improved range of motion after 120 days of supplementation with 40 mg UC-II daily. While results are promising, most trials are industry-funded and involve moderate sample sizes, warranting independent large-scale replication before definitive clinical guidelines can be established.

Nutritional Profile

Chicken Sternum Cartilage (Gallus gallus domesticus) is primarily composed of type II collagen (approximately 50-60% of dry weight), chondroitin sulfate (20-30% of dry weight), and hyaluronic acid (1-5% of dry weight), making it a concentrated source of joint-supportive glycosaminoglycans (GAGs). Protein content is high at approximately 60-70% of dry weight, predominantly as collagen-derived peptides rich in glycine (~33% of amino acid composition), proline (~13%), and hydroxyproline (~10%), which are poorly represented in standard dietary proteins. Chondroitin sulfate concentration is estimated at 200-400 mg per gram of dry cartilage extract, with bioavailability enhanced in native (undenatured) form — commercial standardized extracts (e.g., UC-II) typically deliver 10 mg undenatured type II collagen per 40 mg capsule. Hyaluronic acid content ranges from 10-50 mg per gram of dry weight depending on processing method. Calcium content is moderate at approximately 10-20 mg per gram due to partial mineralization of sternal cartilage. Phosphorus is present at approximately 5-10 mg per gram. Trace amounts of zinc (0.1-0.5 mg/g), magnesium (1-3 mg/g), and manganese (0.05-0.2 mg/g) are detectable, supporting enzymatic collagen synthesis pathways. Fat content is low at 1-5% of dry weight, primarily as phospholipids. Carbohydrate content, excluding GAG chains, is negligible (<2%). Bioavailability note: Undenatured (native) type II collagen is absorbed intact via gut-associated lymphoid tissue (GALT) and operates via oral tolerization mechanisms rather than direct substrate provision, making low doses (10 mg/day) clinically effective. Hydrolyzed forms provide collagen peptides (particularly Pro-Hyp and Hyp-Gly dipeptides) with molecular weights of 0.3-8 kDa, which are absorbed through intestinal epithelium and detected in plasma within 1-2 hours post-ingestion.

Preparation & Dosage

Clinically studied dose: 2g/day of standardized hydrolyzed extract (BioCell Collagen) for 70 days in osteoarthritis patients. Safety studies in animals showed no toxicity at doses up to 1000mg/kg/day for 90 days. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Glucosamine, MSM, Vitamin C, Turmeric, Boswellia

Safety & Interactions

Chicken sternum cartilage supplements are generally well tolerated at the clinically studied dose of 40 mg/day, with adverse event profiles comparable to placebo in controlled trials lasting up to six months. Individuals with poultry or egg allergies should exercise caution, as the product is derived from Gallus gallus domesticus and may trigger hypersensitivity reactions. No significant drug interactions have been formally established, though theoretical caution is advised when co-administering with anticoagulants such as warfarin, given the chondroitin sulfate component's potential mild antiplatelet effects. Safety data in pregnant or breastfeeding women and pediatric populations are insufficient, and use in these groups should be discussed with a healthcare provider before initiating supplementation.